AI for Drug Discovery.
Accelerate development with data.
AI for Drug Discovery.
Accelerate development with data.
Landing Page.
Simple, bold.
Clinical trials are too slow.
Manual eligibility screening takes 3–5 hours per patient. This creates delays, limited patient access, and overworked staff.
80% of trials are delayed.
Delays mean fewer patients get access and results reach the clinic slowly.
We can fix this.
Our AI delivers faster, more reliable patient screening for every trial.
Clinical trials are too slow.
Manual eligibility screening takes 3–5 hours per patient. This creates delays, limited patient access, and overworked staff.
80% of trials are delayed.
Delays mean fewer patients get access and results reach the clinic slowly.
We can fix this.
Our AI delivers faster, more reliable patient screening for every trial.
Clinical trials are too slow.
Manual eligibility screening takes 3–5 hours per patient. This creates delays, limited patient access, and overworked staff.
80% of trials are delayed.
Delays mean fewer patients get access and results reach the clinic slowly.
We can fix this.
Our AI delivers faster, more reliable patient screening for every trial.
5 hours —> 5 minutes
See how DrugDevelopment GPT works.
See Flow
How It Works
5 hours —> 5 minutes
See how DrugDevelopment GPT works.
See Flow
How It Works
5 hours —> 5 minutes
See how DrugDevelopment GPT works.
See Flow
How It Works
Expert-Developed
Protocol-Specific
Transparent
Upload to Output
Data-Driven
Fast & Accurate
Niche Engineered
Clear Logic
Expert-Developed
Protocol-Specific
Transparent
Upload to Output
Data-Driven
Fast & Accurate
Niche Engineered
Clear Logic
Expert-Developed
Protocol-Specific
Transparent
Upload to Output
Data-Driven
Fast & Accurate
Niche Engineered
Clear Logic
2x
Enrollments
85%
Accuracy
10x
Patients Screened
2x
Enrollments
85%
Accuracy
10x
Patients Screened
2x
Enrollments
85%
Accuracy
10x
Patients Screened
Hospitals
Clinical Research Companies
CROs/SMOs
Group Practices
Hospitals
Clinical Research Companies
CROs/SMOs
Group Practices
Hospitals
Clinical Research Companies
CROs/SMOs
Group Practices
Upload Data
Process NLP
Map Logic
Screen Output
Upload Data
Process NLP
Map Logic
Screen Output
Upload Data
Process NLP
Map Logic
Screen Output
Our Team
Founder/CEO:
Huzaifa Hussain. Visionary in digital healthcare—built tools for clinical R&D teams.
Advisors:
Quresh Tyebji – VP of IoT Solutions, Shipcom
Shruti Bagla, Ph.D., EMBA – Genomics & Healthcare Strategy
Arcadio Ramirez – GVSU | Licensing, Clean Tech, and M&A
Dr. Shabbar Danish, M.D. – Chair of Neurosurgery, Hackensack
Contact Us
Careers
We’re growing and always looking for talented, mission-driven people passionate about AI, clinical research, and healthcare innovation.
We’re growing and always looking
We’re growing and always looking
Openings: (1)
Business Development Representative 1
How does DrugDevelopment GPT help clinical trials?
It automates patient eligibility screening, reducing hours of manual review and decreasing delays for faster trial enrollment.
Is the platform secure and HIPAA-compliant?
Yes. Emerge ensures full HIPAA compliance and offers Business Associate Agreements for partners.
Who can use this platform?
Hospitals, CROs, biotech and pharma companies, and physician investigators can all leverage Emerge's technology.
How does DrugDevelopment GPT help clinical trials?
It automates patient eligibility screening, reducing hours of manual review and decreasing delays for faster trial enrollment.
Is the platform secure and HIPAA-compliant?
Yes. Emerge ensures full HIPAA compliance and offers Business Associate Agreements for partners.
Who can use this platform?
Hospitals, CROs, biotech and pharma companies, and physician investigators can all leverage Emerge's technology.
How does DrugDevelopment GPT help clinical trials?
It automates patient eligibility screening, reducing hours of manual review and decreasing delays for faster trial enrollment.
Is the platform secure and HIPAA-compliant?
Yes. Emerge ensures full HIPAA compliance and offers Business Associate Agreements for partners.
Who can use this platform?
Hospitals, CROs, biotech and pharma companies, and physician investigators can all leverage Emerge's technology.
Emerge Research Institute (dba Emerge Biotech) is a Detroit-based digital health company accelerating clinical trials
through AI-driven patient screening and research site innovation.
© 2025 Emerge Research Institute. All rights reserved.